Anbazhagan M - Search Results

1

Diphenyl furans and aza analogs: effects of structural modification on in vitro activity, DNA binding, and accumulation and distribution in trypanosomes.

Mathis AM, Bridges AS, Ismail MA, Kumar A, Francesconi I, Anbazhagan M, Hu Q, Tanious FA, Wenzler T, Saulter J, Wilson WD, Brun R, Boykin DW, Tidwell RR, Hall JE. Mathis AM, et al. Among authors: anbazhagan m. Antimicrob Agents Chemother. 2007 Aug;51(8):2801-10. doi: 10.1128/AAC.00005-07. Epub 2007 May 21. Antimicrob Agents Chemother. 2007. PMID: 17517831 Free PMC article.

2

In vivo investigations of selected diamidine compounds against Trypanosoma evansi using a mouse model.

Gillingwater K, Kumar A, Anbazhagan M, Boykin DW, Tidwell RR, Brun R. Gillingwater K, et al. Among authors: anbazhagan m. Antimicrob Agents Chemother. 2009 Dec;53(12):5074-9. doi: 10.1128/AAC.00422-09. Epub 2009 Sep 28. Antimicrob Agents Chemother. 2009. PMID: 19786604 Free PMC article.

3

Characterizing the fragmentation of 2,5-bis (4-amidinophenyl)furan-bis-O-methylamidoxime and selected metabolites using ion trap mass spectrometry.

Zhou L, Voyksner RD, Thakker DR, Stephens CE, Anbazhagan M, Boykin DW, Hall JE, Tidwell RR. Zhou L, et al. Among authors: anbazhagan m. Rapid Commun Mass Spectrom. 2002;16(11):1078-85. doi: 10.1002/rcm.676. Rapid Commun Mass Spectrom. 2002. PMID: 11992511

4

Metabolites of an orally active antimicrobial prodrug, 2,5-bis(4-amidinophenyl)furan-bis-O-methylamidoxime, identified by liquid chromatography/tandem mass spectrometry.

Zhou L, Thakker DR, Voyksner RD, Anbazhagan M, Boykin DW, Hall JE, Tidwell RR. Zhou L, et al. Among authors: anbazhagan m. J Mass Spectrom. 2004 Apr;39(4):351-60. doi: 10.1002/jms.591. J Mass Spectrom. 2004. PMID: 15103648

5

O-alkoxyamidine prodrugs of furamidine: in vitro transport and microsomal metabolism as indicators of in vivo efficacy in a mouse model of Trypanosoma brucei rhodesiense infection.

Ansede JH, Anbazhagan M, Brun R, Easterbrook JD, Hall JE, Boykin DW. Ansede JH, et al. Among authors: anbazhagan m. J Med Chem. 2004 Aug 12;47(17):4335-8. doi: 10.1021/jm030604o. J Med Chem. 2004. PMID: 15294005

6

Unusual dehydroxylation of antimicrobial amidoxime prodrugs by cytochrome b5 and NADH cytochrome b5 reductase.

Saulter JY, Kurian JR, Trepanier LA, Tidwell RR, Bridges AS, Boykin DW, Stephens CE, Anbazhagan M, Hall JE. Saulter JY, et al. Among authors: anbazhagan m. Drug Metab Dispos. 2005 Dec;33(12):1886-93. doi: 10.1124/dmd.105.005017. Epub 2005 Aug 30. Drug Metab Dispos. 2005. PMID: 16131524

7

Dexamethasone-Free Antiemetic Prophylaxis for Highly Emetogenic Chemotherapy: A Double-Blind, Phase III Randomized Controlled Trial (CINV POD study).

Radhakrishnan V, Venkatakrishnan K, Perumal Kalaiyarasi J, Selvarajan G, Mahaboobasha N, Victor PV, Anbazhagan M, Sivanandam DM, Rajaraman S. Radhakrishnan V, et al. Among authors: anbazhagan m. JCO Glob Oncol. 2024 Jan;10:e2300301. doi: 10.1200/GO.23.00301. JCO Glob Oncol. 2024. PMID: 38237092 Free PMC article. Clinical Trial.

8

A novel CoMoO₄ enwrapped ZIF-8 nanocomposite with enhanced visible light photocatalytic activity.

Vadivel S, Muthuraj A, Anbazhagan M, Abdul Samad S, Arumugam R. Vadivel S, et al. Among authors: anbazhagan m. Environ Pollut. 2023 Nov 1;336:122450. doi: 10.1016/j.envpol.2023.122450. Epub 2023 Aug 26. Environ Pollut. 2023. PMID: 37640225

9

Characterization of Intestinal Mesenchymal Stromal Cells From Patients With Inflammatory Bowel Disease for Autologous Cell Therapy.

Anbazhagan M, Geem D, Venkateswaran S, Pelia R, Kolachala VL, Dodd A, Maddipatla SC, Cutler DJ, Matthews JD, Chinnadurai R, Kugathasan S. Anbazhagan M, et al. Stem Cells Transl Med. 2023 Mar 3;12(2):112-122. doi: 10.1093/stcltm/szad003. Stem Cells Transl Med. 2023. PMID: 36869704 Free PMC article.

10

Complexity of Secretory Chemokines in Human Intestinal Organoid Cultures Ex Vivo.

Cottle C, Anbazhagan M, Lipat A, Patel M, Porter AP, Hogan K, Rajan D, Matthews JD, Kugathasan S, Chinnadurai R. Cottle C, et al. Among authors: anbazhagan m. Gastro Hep Adv. 2022;1(3):457-460. doi: 10.1016/j.gastha.2022.02.009. Epub 2022 Apr 8. Gastro Hep Adv. 2022. PMID: 35634262 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page